Fox Run Management’s UroGen Pharma URGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-36,271
Closed -$401K 1256
2025
Q1
$401K Buy
+36,271
New +$401K 0.06% 577